NEÖ

Natural health product licensed in Canada

Other names: FÖRE, NEÖ Mint, NEÖ Mint Nicotine Pouch, NEÖ Nicotine Pouch, Ö
Licence holder: Swedish Smokeless Solutions AB
NPN or DIN-HM: 80143522
Status: Active licence
Licence date: 21 August 2025
Revision date: 22 September 2026
Form: Pochette
Route of administration: Buccale
Application type: Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source
1-Méthyl-2-(3-pyridyl)pyrrolidine Source : Nicotine polacrilex	4 mg

Non-medicinal ingredients

Ethanol, Alcool benzylique, Alginate de sodium, Acide l-tartrique, Huile de menthe poivrée, Propylène glycol, Gomme de xanthane, Cellulose microcristalline, Chlorure de sodium, Carbonate de sodium anhydre, Bicarbonate de sodium, Huile de menthe verte, Éthyl menthane carboxamide, Triméthyl Isopropyl Butanamide, Glycérol, Eau

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Pouch	minimum: 1 Tous les jours ; maximum: 15 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

NEÖ Nicotine Pouches are a form of Nicotine Replacement Therapy. They can help you quit smoking by delivering nicotine to your body, and thereby reducing withdrawal symptoms and nicotine cravings. NEÖ Nicotine Pouches provide nicotine as part of a Nicotine Replacement Therapy program, which can increase the chance of quitting smoking successfully. They provide a partial substitution for nicotine in cigarettes and thereby can reduce the number of cigarettes you smoke. NEÖ is a Nicotine Replacement Therapy that can be used anytime, anywhere to temporarily control or satisfy nicotine cravings fast.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.